Discontinued — last reported Q4 '25
Medtronic Medical Surgical — Depreciation expense increased by 17.0% to $62.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.6%, from $51.00M to $62.00M. Over 2 years (FY 2021 to FY 2023), Medical Surgical — Depreciation expense shows relatively stable performance with a 1.8% CAGR.
An increase often signals significant capital investment in new production capacity or technology, whereas a decrease may indicate aging infrastructure or reduced capital expenditure cycles.
This metric represents the systematic allocation of the cost of tangible assets, such as manufacturing equipment and pro...
Standard across all capital-intensive manufacturing industries; comparable to depreciation charges reported in the segment notes of other medical technology firms.
mdt_segment_medical_surgical_depreciation_expense| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.75M | $50.00M | $50.00M | $50.00M | $50.00M | $50.50M | $50.50M | $50.50M | $50.50M | $49.00M | $51.00M | $51.00M | $54.00M | $53.00M | $62.00M |
| QoQ Change | — | +2.6% | +0.0% | +0.0% | +0.0% | +1.0% | +0.0% | +0.0% | +0.0% | -3.0% | +4.1% | +0.0% | +5.9% | -1.9% | +17.0% |
| YoY Change | — | — | — | — | +2.6% | +1.0% | +1.0% | +1.0% | +1.0% | — | — | — | +10.2% | +3.9% | +21.6% |